Vice President, Business Development
Miami, Florida, Us
• Led Business Development for all business segments, oversee pre-launch commercialization teams• As a key member of the senior leadership team, I routinely participated in and contributed to decision-making regarding strategy and financial planning, including P&L management, both for my specific area and for the company overall.• Concluded multiple out-licensing, divestitures, co-promotion, in-licensing, supply chain deals, including one that has resulted in a fourfold increase in annual revenues of our CNS specialty pharma unit, from $25MM to over $100MM, and another that established a Women’s Health unit that generated over $150MM in annual sales for Noven.• Company restructuring in late 2018, early 2019 presented the opportunity to demonstrate leadership ability across a diverse range of responsibilities. Executive Sponsor/Leader, Product Launch Readiness. Designated by CEO to lead the prelaunch strategy and planning for first transdermal patch for the treatment of schizophrenia. Product will be introduced to the market in April 2020. Led all strategic planning, including engineering a major change in how the company will work with managed care and prescription drug coverage payers and distributors. Executive Sponsor/Leader, Product Portfolio Development. After handing off product launch responsibilities to Noven’s new Head of Marketing and Sales in June 2019, I was asked to assume leadership of the Noven pipeline development team, consisting of representatives from a diverse set of functional experts, including clinical, regulatory, product development/pharmacology, market analytics, new product commercialization, project planning, and intellectual property. We introduced three differentiated products into the pipeline by January 2020.
